Abstract
Prostate specific antigen is the most important tumour marker in the study of prostatic cancer. The role of PSA in the management of prostatic carcinoma has been clarified in the diagnostic and prognostic stage, but several controversies persist over prediction of final pathological stage. We present our experience and discuss our results in 70 radical prostatectomies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
